Saturday, March 17, 2012 10:14:54 AM
Does anyone think for one second that Whelan and everyone else inside BIEL isn't crawling out of their skin with impatience? I sure would be, I'm twitching thinking about it. And the ALLAY application covers menstrual pain and cramps for women who will no longer have to take drugs every month? Huge market!
I like where we are and the fact that the guy who stands to win the most is the largest shareholder in the company. If I'm CEO of J&J I'm watching this like a hawk. When BIEL gets approval, it's an instant target! And if J&J gets it, J&J just bought an edge on all its drug competitors. Nice place to be.
I know I'm being repetitive, but it just makes no sense to me that a surgeon can prescribe the already approved RecoveryRx for me after he operates on my eye, to promote better, faster recovery/healing and I can wear a RecoveryRX next to my brain and the FDA won't approve ALLAY for women and ActiPatch for aches, pain, sprains, etc. I'm staying right where I am, patiently waiting for approval. Happy St. Pati's Day
FEATURED Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM